Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Tissue Regenix CEO excited to soon be selling first products in UK

Steve Couldwell, chief executive of Tissue Regenix Group PLC (LON:TRX), caught up with Proactive's Andrew Scott following the appointment of Gareth Hywel Jones as their chief financial officer as well as the big news last month that they've been granted a Human Tissue Authority licence which will allow them to import and distribute their US-made products in the UK market.

The licence will initially be used to import CellRight’s BioRinse portfolio of bone healing products which are made at its Texas manufacturing facility.

They've also recently inked a non-exclusive three-year distribution agreement with Pennine Healthcare.

Pennine has an “established presence” in the UK orthopaedic market which should help to drive sales of Tissue’s bone and soft tissue products.

 
Meet Grit Real Estate Income Group Ltd, Kogi Iron Ltd, Ethernity Networks Ltd and Advanced Blast & Ballistic Systems Ltd at our event, London , 15 November 2018. Register here »
View full TRX profile View Profile

Tissue Regenix Group PLC Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use